New York City, NY -- (SBWIRE) -- 10/22/2013 -- StockMarketIntel.com issues a special report on the following stocks: DURECT Corporation (NASDAQ:DRRX), Sprint Corporation (NYSE:S), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), DryShips Inc. (NASDAQ:DRYS)
DURECT Corporation (NASDAQ:DRRX) gained 8.57% recently, while trading on 3.71million shares at the price of $1.52. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.61 and was moved to its maximum level of $1.85.The stock changed hands in a range of $1.38 to $1.56, bringing its market capitalization at about $154.07 million. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA), with one program in Phase III with an NDA in preparation, two programs in Phase II and three programs in Phase I.
Why Should Investors Buy DRRX After the Recent Fall? Just Go Here and Find Out
Sprint Corporation (NYSE:S) declined -0.08% recently, in the current trading session, at $6.34 with a total volume of 5.98 million shares. The stock, on average, trades on a volume of 7.59 million shares. In the past 52 weeks, the share price has not declined below $5.15 and above $7.26.It floated in a range of $6.30 to $6.46.Its market capitalization now moved to about $24.94 billion.
Will Sprint Corporation Get Buyers Even After The Recent Rally? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) recently recorded a gain of 4.42% and was moving within a range of $3.00-$3.17. Its current trading price is $3.08. The share price hit its 52-week low of $2.62 and $24.59 was the best price. The stock completed the day with a total volume of 6.84 million shares, versus an average volume of 13.94 million shares. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
Will ARIA Bounce Back After yesterday’s Sharp Sell off? Find Out Here
DryShips Inc. (NASDAQ:DRYS) declined -0.32% in its current trading activity, bringing its market capitalization around $1.24 billion. The total number of shares that changed hands during the current session up till now was 5.91 million shares, as compared to average trading volume of 19.45 million shares. The share price after opening at $3.02 made a high of $3.17 and hovered above $3.00, while its recent trading price was $3.08. DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units.
Is it the Right to Grab DRYS after the Recent Slump? Get Free Trend Analysis Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)